Stay updated with breaking news from மெர்வின் டர்னர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EXCLUSIVE: Lauren Parker - Stepping out of her comfort zone proboxing-fans.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proboxing-fans.com Daily Mail and Mail on Sunday newspapers.
Jim Evans was a true hero within the British boxing circuit, not hugely famous outside our bubble but there were few who garnered more respect inside it, writes Matt Christie JIM EVANS made his way down the stairs of his home in Maidenhead, turned right into the kitchen, smiled at his darling wife Georgina, sipped the tea she’d made exactly the way he liked it, placed a newspaper under his arm, walked through the patio doors, down the steps into his garden, turned left at the bottom, trotted down a small path, then unlocked the door to his own private gym, turned on the lights and eased himself into his favourite armchair. Paradise. ....
Published: Dec 18, 2020 By Alex Keown Cidara Therapeutics – Christopher Kurtz was named executive vice president of Technical Operations at Cidara Therapeutics. Kurtz brings more than 26 years of experience in global manufacturing, engineering, supply chain, CMC development and program management for drugs and devices at various stages of development. Prior to joining Cidara, Kurtz served as head of commercial API manufacturing at Gilead Sciences. He previously served as vice president, for drug device industrialization at AbbVie, where he led product scale-up and industrialization projects for drug-device combinations. Prior to that, Kurtz held a number of leadership positions at various companies, including Monsanto, Nektar Therapeutics, Alza Corporation, Alexza and Novo Nordisk. ....
Press release content from Business Wire. The AP news staff was not involved in its creation. SAB Biotherapeutics Announces New Appointments to its Board of Directors December 16, 2020 GMT SIOUX FALLS, S.D. (BUSINESS WIRE) Dec 16, 2020 SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the need for human serum, today announced the appointment of Mani Mohindru, PhD, and Mervyn Turner, PhD to its Board of Directors. “We are excited to welcome Drs. Mohindru and Turner to our Board of Directors. Each industry executive brings a wealth of corporate strategy, drug development and financial expertise,” said Eddie J. Sullivan, PhD, co-founder, president and CEO of SAB Biotherapeutics. “Both Drs. Mohindru and Turner are joining SAB at a pivotal time as we continue to advance a new class of immunotherapies that leve ....
SAB Biotherapeutics, Inc.: SAB Biotherapeutics Announces New Appointments to its Board of Directors SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the need for human serum, today announced the appointment of Mani Mohindru, PhD, and Mervyn Turner, PhD to its Board of Directors. We are excited to welcome Drs. Mohindru and Turner to our Board of Directors. Each industry executive brings a wealth of corporate strategy, drug development and financial expertise, said Eddie J. Sullivan, PhD, co-founder, president and CEO of SAB Biotherapeutics. Both Drs. Mohindru and Turner are joining SAB at a pivotal time as we continue to advance a new class of immunotherapies that leverage the native human immune response and match the evolution of human disease. We look forward to their contributions as we develop our robust pipeline, ....